Emerald Advisers, LLC Clovis Oncology, Inc. Transaction History

Emerald Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$11.63 - $32.67 $4.45 Million - $12.5 Million	-382,705 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$29.37 - $49.48 $812,726 - $1.37 Million	27,672 Added 7.79%	382,705 $11.2 Million
Q2 2018 Jul 31, 2018	BUY	$42.06 - $62.4 $6.23 Million - $9.24 Million	148,107 Added 71.57%	355,033 $16.1 Million
Q1 2018 Apr 26, 2018	SELL	$50.12 - $67.72 $2.66 Million - $3.6 Million	-53,143 Reduced 20.43%	206,926 $10.9 Million
Q4 2017 Feb 05, 2018	SELL	$57.69 - $84.58 $4.23 Million - $6.2 Million	-73,327 Reduced 21.99%	260,069 $17.7 Million

Q3 2017 Oct 30, 2017	BUY	$67.17 - $84.81 $22.4 Million - $28.3 Million	333,396	333,396 $27.5 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.